Clinical Trials Logo

Chronic Diarrhea clinical trials

View clinical trials related to Chronic Diarrhea.

Filter by:

NCT ID: NCT06152289 Recruiting - Crohn Disease Clinical Trials

Development of New Diagnostic Tools in Capsule Endoscopy

NOCE
Start date: February 10, 2023
Phase:
Study type: Observational

Patients participating to this study will provide images and videos of capsule endoscopy to train, tune and evaluate technological bricks of artificial intelligence solutions, in order to improve diagnostic performances of the procedure, while reducing reading time by physicians.

NCT ID: NCT05811091 Not yet recruiting - Chronic Diarrhea Clinical Trials

Pathological Patterns in Chronic Diarrhea With Normal Colonoscopy

Start date: March 5, 2024
Phase:
Study type: Observational

To asses prevalence of pathological findings in patients with chronic diarrhea and normal colonoscopy

NCT ID: NCT05724381 Not yet recruiting - Chronic Diarrhea Clinical Trials

Auramine Phenol Staining Technique for Revealing Different Coccidian Parasites

Start date: March 2023
Phase:
Study type: Observational

The increased number of documented human coccidian infections, including Cryptosporidium parvum, Cyclospora cayetanensis, Isospora belli, and Sarcocystis spp., that are often indistinguishable from other forms of community-acquired diarrhea, together with the possibility of treating some of them, suggests a need for proper diagnostic techniques to recover and identify these organisms

NCT ID: NCT05702190 Completed - Chronic Diarrhea Clinical Trials

Opium Tincture Against Chronic Diarrhea - Healthy

Start date: March 9, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the mechanistic anti-propulsive effects of opium tincture on the gastrointestinal tract of a cohort of healthy participants.

NCT ID: NCT05690321 Completed - Chronic Diarrhea Clinical Trials

Opium Tincture Against Chronic Diarrhea - Patients

Start date: November 17, 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study is to investigate the mechanistic anti-propulsive effects of opium tincture on the gastrointestinal tract of a cohort of patients with chronic diarrhea

NCT ID: NCT05130047 Completed - Clinical trials for Irritable Bowel Syndrome With Diarrhea

Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM)

Start date: December 1, 2021
Phase: Phase 2
Study type: Interventional

This single-center, randomized, double-blind, placebo-controlled study is designed to compare effects of aldafermin, (NGM282), 1 mg, and placebo given daily by subcutaneous injection on bowel functions and hepatic synthesis and fecal excretion of bile acids in patients with diarrhea associated with bile acid malabsorption (BAM).

NCT ID: NCT03876717 Completed - Chronic Diarrhea Clinical Trials

Effect of the Sequestrant Colesevelam in Bile Acid Diarrhoea

SINBAD
Start date: October 25, 2018
Phase: Phase 4
Study type: Interventional

Bile acid diarrhoea is a chronic disease that impairs quality of life. One in 100 has the condition and many suffer from the disease without knowing. The current test is called SeHCAT and is expensive and time-consuming and is unavailable in many places, including the US. The disease is often misdiagnosed as irritable bowel syndrome and estimated one third of patients with irritable bowel syndrome of the mixed type and the diarrhoea predominant type suffer from bile acid diarrhoea without knowing. A blood test called 7α-hydroxy-4-cholestene-3-one (C4) could make it much easier to diagnose bile acid diarrhoea. To establish the new test, the results of both C4 and SeHCAT are compared with the treatment effect of the drug called colesevelam. We invite patients who are referred for the SeHCAT test to participate in the trial. The SeHCAT test takes two days that are one week apart. The study patients register stool habits with a diary in the week between the SeHCAT visits. Based on the diary results, we screen for eligibility; e.g. a certain degree/severity of diarrhoea is required for participation. We treat eligible study patients (i.e those with diarrhoea) with either colesevelam or placebo (medicine without effect) that is randomly assigned. 170 study patients need to complete the treatment. We aim to validate (ie. compare) both the C4-test and the SeHCAT test with the colesevelam treatment response as the reference.

NCT ID: NCT03598010 Not yet recruiting - Diarrhea Clinical Trials

Safety, Tolerability and Preliminary Efficacy of Lenodiar Pediatric in Diarrhea

Start date: October 2019
Phase: N/A
Study type: Interventional

Evaluation of the efficacy of a treatment with Actitan-F, a natural molecular complex of tannins (from Agrimony and Tormentil) and flavonoids (Chamomile) in a pediatric population of children affected by acture/prolonged/chronic diarrhea

NCT ID: NCT03270085 Completed - Clinical trials for Irritable Bowel Syndrome With Diarrhea

Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption

Start date: December 7, 2017
Phase: Phase 2
Study type: Interventional

To compare with a randomized trial (n=15 per treatment group), effects of colesevelam and placebo treatment, on colonic transit, bowel functions, permeability and tight junction expression in rectosigmoid mucosa of IBS-D with Bile Acid Malabsorption.

NCT ID: NCT03269305 Completed - Chronic Diarrhea Clinical Trials

An Audit on Management of Chronic Diarrhea

AAOMOCD
Start date: September 1, 2017
Phase:
Study type: Observational

The study is to assess whether the staff in gastroenterology unit are sticking to the agreed up on unit's protocol in management of chronic diarrhea over the period of one year(september 2017-september 2018)